Login / Signup

Why falsified medicines reach patients: an analysis of political and economic factors in Romania.

Adina-Loredana NistorElizabeth PisaniMaarten Olivier Kok
Published in: BMJ global health (2023)
Strategies against falsified medicine with a narrow focus on safeguarding quality in the regulated supply are insufficient. To protect patients, governments must also ensure that patients have access to affordable medicines, as shortages provide an opportunity for those selling fake products.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • ejection fraction
  • peritoneal dialysis